Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.
<h4>Background</h4>The parasitic flatworm Schistosoma mansoni is a blood fluke that causes schistosomiasis. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control disease is a combination of dr...
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Public Library of Science (PLoS)
2014-03-01
|
| Seri Bilgileri: | PLoS Neglected Tropical Diseases |
| Online Erişim: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002750&type=printable |
| _version_ | 1826866278645628928 |
|---|---|
| author | Vicente P Martins Suellen B Morais Carina S Pinheiro Natan R G Assis Barbara C P Figueiredo Natasha D Ricci Juliana Alves-Silva Marcelo V Caliari Sergio C Oliveira |
| author_facet | Vicente P Martins Suellen B Morais Carina S Pinheiro Natan R G Assis Barbara C P Figueiredo Natasha D Ricci Juliana Alves-Silva Marcelo V Caliari Sergio C Oliveira |
| author_sort | Vicente P Martins |
| collection | DOAJ |
| description | <h4>Background</h4>The parasitic flatworm Schistosoma mansoni is a blood fluke that causes schistosomiasis. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control disease is a combination of drug treatment and immunization with an anti-schistosome vaccine. Numerous antigens that are expressed at the interface between the parasite and the mammalian host have been assessed. Among the most promising molecules are the proteins present in the tegument and digestive tract of the parasite.<h4>Methodology/principal findings</h4>In this study, we evaluated the potential of Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, for use as part of a recombinant vaccine. We confirmed by real-time PCR that Sm10.3 was expressed at all stages of the parasite life cycle. The localization of Sm10.3 on the surface and lumen of the esophageal and intestinal tract in adult worms and lung-stage schistosomula was confirmed by confocal microscopy. We also show preliminary evidence that rSm10.3 induces erythrocyte agglutination in vitro. Immunization of mice with rSm10.3 induced a mixed Th1/Th2-type response, as IFN-γ, TNF-α, and low levels of IL-5 were detected in the supernatant of cultured splenocytes. The protective effect conferred by vaccination with rSm10.3 was demonstrated by 25.5-32% reduction in the worm burden, 32.9-43.6% reduction in the number of eggs per gram of hepatic tissue, a 23.8% reduction in the number of granulomas, an 11.8% reduction in the area of the granulomas and a 39.8% reduction in granuloma fibrosis.<h4>Conclusions/significance</h4>Our data suggest that Sm10.3 is a potential candidate for use in developing a multi-antigen vaccine to control schistosomiasis and provide the first evidence for a possible role for Sm10.3 in the blood feeding process. |
| first_indexed | 2024-12-22T09:02:42Z |
| format | Article |
| id | doaj.art-3c8a6595b8b64cfe9ceda1f08e258a7b |
| institution | Directory Open Access Journal |
| issn | 1935-2727 1935-2735 |
| language | English |
| last_indexed | 2025-02-16T21:56:58Z |
| publishDate | 2014-03-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj.art-3c8a6595b8b64cfe9ceda1f08e258a7b2025-01-16T05:32:27ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-03-0183e275010.1371/journal.pntd.0002750Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.Vicente P MartinsSuellen B MoraisCarina S PinheiroNatan R G AssisBarbara C P FigueiredoNatasha D RicciJuliana Alves-SilvaMarcelo V CaliariSergio C Oliveira<h4>Background</h4>The parasitic flatworm Schistosoma mansoni is a blood fluke that causes schistosomiasis. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control disease is a combination of drug treatment and immunization with an anti-schistosome vaccine. Numerous antigens that are expressed at the interface between the parasite and the mammalian host have been assessed. Among the most promising molecules are the proteins present in the tegument and digestive tract of the parasite.<h4>Methodology/principal findings</h4>In this study, we evaluated the potential of Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, for use as part of a recombinant vaccine. We confirmed by real-time PCR that Sm10.3 was expressed at all stages of the parasite life cycle. The localization of Sm10.3 on the surface and lumen of the esophageal and intestinal tract in adult worms and lung-stage schistosomula was confirmed by confocal microscopy. We also show preliminary evidence that rSm10.3 induces erythrocyte agglutination in vitro. Immunization of mice with rSm10.3 induced a mixed Th1/Th2-type response, as IFN-γ, TNF-α, and low levels of IL-5 were detected in the supernatant of cultured splenocytes. The protective effect conferred by vaccination with rSm10.3 was demonstrated by 25.5-32% reduction in the worm burden, 32.9-43.6% reduction in the number of eggs per gram of hepatic tissue, a 23.8% reduction in the number of granulomas, an 11.8% reduction in the area of the granulomas and a 39.8% reduction in granuloma fibrosis.<h4>Conclusions/significance</h4>Our data suggest that Sm10.3 is a potential candidate for use in developing a multi-antigen vaccine to control schistosomiasis and provide the first evidence for a possible role for Sm10.3 in the blood feeding process.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002750&type=printable |
| spellingShingle | Vicente P Martins Suellen B Morais Carina S Pinheiro Natan R G Assis Barbara C P Figueiredo Natasha D Ricci Juliana Alves-Silva Marcelo V Caliari Sergio C Oliveira Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. PLoS Neglected Tropical Diseases |
| title | Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. |
| title_full | Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. |
| title_fullStr | Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. |
| title_full_unstemmed | Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. |
| title_short | Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. |
| title_sort | sm10 3 a member of the micro exon gene 4 meg 4 family induces erythrocyte agglutination in vitro and partially protects vaccinated mice against schistosoma mansoni infection |
| url | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002750&type=printable |
| work_keys_str_mv | AT vicentepmartins sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT suellenbmorais sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT carinaspinheiro sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT natanrgassis sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT barbaracpfigueiredo sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT natashadricci sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT julianaalvessilva sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT marcelovcaliari sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection AT sergiocoliveira sm103amemberofthemicroexongene4meg4familyinduceserythrocyteagglutinationinvitroandpartiallyprotectsvaccinatedmiceagainstschistosomamansoniinfection |